Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2010
12/16/2010WO2010099044A9 Treatment of immunosuppression-related disorders
12/16/2010WO2010093890A3 Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides
12/16/2010WO2010083241A3 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
12/16/2010WO2010013143A3 Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus
12/16/2010US20100317865 Enzyme and receptor modulation
12/16/2010US20100317735 High eicosapentaenoic acid oils from improved optimized strains of yarrowia lipolytica
12/16/2010US20100317729 New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin
12/16/2010US20100317688 2-HETEROAROYLIMIDAZOL[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317687 2-BENZOYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
12/16/2010US20100317686 N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317685 N-PHENYL-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317676 Fused heterocyclic compounds, and compositions and uses thereof
12/16/2010US20100317675 6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317674 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
12/16/2010US20100317673 N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317670 Therapeutic agents useful for treating pain
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317659 Jak kinase modulating compounds and methods of use thereof
12/16/2010US20100317656 IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPEUTICS
12/16/2010US20100317654 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12/16/2010US20100317652 Compounds Useful In Therapy
12/16/2010US20100317649 S1P Receptor Modulating Compounds and Use Thereof
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317643 Janus kinase inhibitor compounds and methods
12/16/2010US20100317634 Piperidyl-propane-thiol ccr3 modulators
12/16/2010US20100317630 Novel heterocyclic compounds as mglu5 antagonists
12/16/2010US20100317629 Dissolvable pharmaceutical implant
12/16/2010US20100317620 N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE COMPOUNDS, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317603 Treatment of Cancer and Inflammatory Disorder
12/16/2010US20100317591 Use of lipid conjugates in the treatment of diseases
12/16/2010US20100317584 Pharmaceutical composition, package and method for rapidly reducing the uric acid in blood
12/16/2010US20100317564 Immunoregulatory peptides and methods of use
12/16/2010US20100316742 Systems and methods for treating fibromyalgia
12/16/2010US20100316734 Methods of thermograph-guided medical treatment
12/16/2010US20100316727 Treatment of inflammatory disorders with ozone
12/16/2010US20100316725 Reduction of flake-like aggregation in nanoparticulate active agent compositions
12/16/2010US20100316723 Compositions and methods for treating inflammation
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316685 Dental Uses of Silver Hydrosol
12/16/2010US20100316680 Anti-inflammatory properties of marine lipid compositions
12/16/2010US20100316676 Bisphosphonate Compounds and Methods for Bone Resorption Diseases, Cancer, Bone Pain, Immune Disorders, and Infectious Diseases
12/16/2010US20100316641 Engineered antibody constant domain molecules
12/16/2010US20100316636 Method of Treating Rheumatoid Arthritis with an IL-6R Antibody
12/16/2010US20100316631 Water Soluble Curcumin-Based Compounds
12/16/2010US20100316627 Human antibodies to human IL-6 receptor
12/16/2010US20100316615 Antisense Oligonucleotides Against VR1
12/16/2010US20100316607 Hepatitis c virus inhibitors
12/16/2010US20100316605 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010US20100316596 Compositions and methods for treatment of diseases and disorders associated with cytokine signaling
12/16/2010US20100316573 Organic Compounds
12/16/2010DE102009024542A1 Zusammensetzungen auf Basis von Chitosan-Oligosacchariden Compositions based on chitosan-oligosaccharides
12/16/2010CA2774883A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010CA2765271A1 Silver hydrosol, dental application and other uses thereof
12/16/2010CA2765171A1 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
12/16/2010CA2765169A1 Model systems and treatment regimes for treatment of neurological disease
12/16/2010CA2764622A1 Substituted benzimidazoles, benzothiazoles and benzoxazoles
12/16/2010CA2764567A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010CA2764430A1 Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof
12/16/2010CA2763092A1 Use of a composition for the treatment of mucositis
12/16/2010CA2760887A1 Oxazole and thiazole derivatives as alx receptor agonists
12/15/2010EP2261251A2 Methods for the synthesis of a modified hemoglobin solution
12/15/2010EP2261249A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261248A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261247A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2261211A1 1,4-dihydropyridine derivatives and their uses
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof
12/15/2010EP2260871A2 Inclusion complexes comprising piroxicam, a cyclodextrin and arginine
12/15/2010EP2260869A2 Pharmaceutical product
12/15/2010EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents
12/15/2010EP2260855A1 Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same
12/15/2010EP2260853A2 Biocompatible polymers for a medical composition
12/15/2010EP2260843A2 Alpha-MSH and derivatives for the induction of tolerance against antigens
12/15/2010EP2260842A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass
12/15/2010EP2260837A1 Pharmaceutical compositions for the coordinated delivery of NSAIDs
12/15/2010EP2260038A1 Purine derivatives as a3 receptor- selective agonists
12/15/2010EP2259789A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition
12/15/2010EP2259785A2 Fullerene therapies for inflammation
12/15/2010EP1914232B1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivatives
12/15/2010EP1827495B1 Painkilling association comprising a dihydroimidazopyrazine derivative
12/15/2010EP1740578B1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
12/15/2010EP1594441B1 Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing the same
12/15/2010EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010EP1404174B1 Anti-infective compositions for treating disordered tissue such as cold sores
12/15/2010CN1989955B Biphenylacetic acid cataplasms
12/15/2010CN1939427B Prickly polygonum extract, its preparation, medicinal composition and use
12/15/2010CN1919848B bilobalide K and complex thereof, preparation method and use for the same
12/15/2010CN1919222B Process for preparing notoginsen triterpenes
12/15/2010CN1872161B Drop pills of Chaihuang, and preparation method
12/15/2010CN101918549A Improved humanized anti-human alpha9-integrin antibody
12/15/2010CN101918443A Antigen associated with rheumatoid arthritis
12/15/2010CN101918381A Substituted benzoazole PDE4 inhibitors for treating pulmonary and cardiovascular disorders
12/15/2010CN101918380A Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and cns disorders
12/15/2010CN101917997A Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy
12/15/2010CN101917990A Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 1272